Workflow
仙琚制药(002332) - 2019 Q1 - 季度财报
XJZYXJZY(SZ:002332)2019-04-24 16:00

Financial Performance - The company's revenue for Q1 2019 was ¥835,738,416.97, representing a 0.70% increase compared to ¥829,940,103.40 in the same period last year[10]. - Net profit attributable to shareholders was ¥58,010,342.60, a significant increase of 43.23% from ¥40,501,223.77 in the previous year[10]. - Basic and diluted earnings per share both increased by 50.00% to ¥0.06 from ¥0.04 in the previous year[10]. - Net profit for the current period was ¥73,803,935.73, up from ¥49,166,573.45 in the previous period, indicating a significant increase of approximately 50.2%[57]. - The net profit attributable to the parent company was ¥58,010,342.60, compared to ¥40,501,223.77 in the previous period, reflecting an increase of around 43.2%[57]. - The company reported a total profit of ¥93,143,977.57, compared to ¥69,988,303.55 in the previous period, showing an increase of about 33.2%[57]. - Total comprehensive income reached ¥23,972,321.17, an increase from ¥19,228,564.19 in the previous period[67]. Cash Flow - The net cash flow from operating activities improved to ¥102,508,038.15, a remarkable increase of 181.21% compared to a negative cash flow of ¥126,233,633.02 in the same period last year[10]. - Cash inflow from operating activities totaled ¥794,392,215.40, slightly up from ¥790,099,095.83 in the previous period[71]. - Cash outflow from operating activities was ¥691,884,177.25, down from ¥916,332,728.85 year-over-year[71]. - Total cash outflow for operating activities was ¥287,756,258.29, down from ¥373,717,797.10 year-over-year[76]. - Net cash flow from investing activities was negative at ¥20,865,453.73, compared to a negative ¥10,606,156.46 in the previous period[74]. - Net cash flow from financing activities decreased to negative ¥4,530,098.04 from positive ¥51,305,188.08 year-over-year[74]. - The net increase in cash and cash equivalents was $31.08 million, a turnaround from a decrease of $25.05 million in the previous period[80]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,598,109,969.57, reflecting a 2.84% increase from ¥5,443,275,372.92 at the end of the previous year[10]. - The total liabilities increased to CNY 2,815,657,035.61 from CNY 2,732,960,522.70, representing a growth of approximately 3.0%[40]. - The total owner's equity rose to CNY 2,782,452,933.96 from CNY 2,710,314,850.22, indicating an increase of about 2.7%[43]. - The company's cash and cash equivalents increased to CNY 710,407,177.76 from CNY 684,346,623.61, reflecting a growth of approximately 3.4%[44]. - Total liabilities were reported at $2.73 billion, with current liabilities at $1.61 billion and non-current liabilities at $1.13 billion, reflecting a balanced liability structure[84]. - Total equity was reported at $2,410,517,531.36, with retained earnings of $447,445,773.88[91]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,752, indicating a stable shareholder base[14]. - The top ten shareholders held a combined 55.01% of the company's shares, with the largest shareholder owning 21.55%[14]. Operational Metrics - The weighted average return on equity was 2.18%, up from 1.71% in the same period last year, indicating improved profitability[10]. - Total operating costs decreased to ¥747,357,191.53 from ¥766,027,715.39, marking a reduction of about 2.2%[54]. - Research and development expenses rose to ¥22,398,036.17 from ¥18,945,458.98, which is an increase of approximately 18.9%[54]. - The company experienced a decrease in asset impairment losses from ¥11,219,810.17 to ¥6,552,555.46, a reduction of about 41.8%[54]. Changes in Financial Standards - The company adopted new financial instrument standards, adjusting "available-for-sale financial assets" of $18.65 million to "other equity instruments," with no impact on prior year financial metrics[81]. - The company did not provide retrospective adjustments for prior comparative data under the new financial instrument and leasing standards[92].